Moderna and ILCM Announce Collaboration to Develop mRNA Therapeutic for CN-1 September 9, 2021 Auto Bot News 0 Moderna announced a collaboration to develop a new mRNA therapeutic for Crigler-Najjar Syndrome Type 1 at no cost to patients.
